共 50 条
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
被引:7
|作者:
Visciano, Maria Luisa
[1
]
Tagliamonte, Maria
[1
]
Stewart-Jones, Guillaume
[2
]
Heyndrickx, Leo
[3
]
Vanham, Guido
[3
]
Jansson, Marianne
[4
]
Fomsgaard, Anders
[5
]
Grevstad, Berit
[5
]
Ramaswamy, Meghna
[6
]
Buonaguro, Franco M.
[1
]
Tornesello, Maria Lina
[1
]
Biswas, Priscilla
[7
]
Scarlatti, Gabriella
[7
]
Buonaguro, Luigi
[1
]
机构:
[1] IRCCS, Fdn Pascale, Ist Nazl Studio & Cura Tumori, Mol Biol & Viral Oncogenesis Unit,Dept Expt Oncol, Naples, Italy
[2] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England
[3] Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium
[4] Lund Univ, Dept Lab Med, Lund, Sweden
[5] Statens Serum Inst, DK-2300 Copenhagen, Denmark
[6] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England
[7] Ist Sci San Raffaele, I-20132 Milan, Italy
来源:
JOURNAL OF TRANSLATIONAL MEDICINE
|
2013年
/
11卷
关键词:
IMMUNODEFICIENCY-VIRUS TYPE-1;
ENVELOPE GLYCOPROTEIN COMPLEX;
HUMAN MONOCLONAL-ANTIBODY;
NEUTRALIZING ANTIBODIES;
MONOMERIC GP120;
IMMUNOGENICITY;
PARTICLES;
EPITOPE;
SUBTYPE;
BREADTH;
D O I:
10.1186/1479-5876-11-165
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutralizing activity against homologous and heterologous viruses. In the present study, we generated a recombinant trimeric soluble gp140, derived from a previously identified Ugandan A-clade HIV field isolate (gp140(94UG018)). Antibodies elicited in immunized rabbits show a broad binding pattern to HIV envelopes of different clades. An epitope mapping analysis reveals that, on average, the binding is mostly focused on the C1, C2, V3, V5 and C5 regions. Immune sera show neutralization activity to Tier 1 isolates of different clades, demonstrating cross clade neutralizing activity which needs to be further broadened by possible structural modifications of the clade A gp140(94UG018). Our results provide a rationale for the design and evaluation of immunogens and the clade A gp140(94UG018) shows promising characteristics for potential involvement in an effective HIV vaccine with broad activity.
引用
收藏
页数:11
相关论文